BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes - Berry, Donald A.; Iversen, Edwin S.; Gudbjartsson, Daniel F.; Hiller, Elaine H.; Garber, Judy E.; Peshkin, Beth N.; Lerman, Caryn; Watson, Patrice; Lynch, Henry T.; Hilsenbeck, Susan G.; Rubinstein, Wendy S.; Hughes, Kevin S.; et al. (Journal of clinical oncology, 2002)
Keywords: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Breast Neoplasms - epidemiology; Breast Neoplasms - genetics; Breast Neoplasms - prevention & control; Breast Neoplasms, Male - epidemiology; Breast Neoplasms, Male - genetics; Breast Neoplasms, Male - prevention & control; Decision Making, Computer-Assisted; Female; Genes, BRCA1; Genes, BRCA2; Genetic Carrier Screening; Genetic Predisposition to Disease - epidemiology; Genetic Testing - methods; Gynecology. Andrology. Obstetrics; Humans; Male; Mammary gland diseases; Medical sciences; Middle Aged; Ovarian Neoplasms - epidemiology; Ovarian Neoplasms - genetics; Ovarian Neoplasms - prevention & control; Pedigree; Prevalence; Probability; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tumors; United States - epidemiology; United States; North America; America; Human; Validation; Prevalence; Malignant tumor; Medical screening; Epidemiology; Mammary gland diseases; Biomedical data processing; Sensitivity; Computer program; Predisposition; Genetics; Mammary gland; Mutation; Public health; Computer aid; Tumor suppressor gene